413 related articles for article (PubMed ID: 33742560)
1. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Antitumor Effect of Sorafenib in Combination with ATM Inhibitor in Hepatocellular Carcinoma Cells.
Liu J; Liu Y; Meng L; Ji B; Yang D
Int J Med Sci; 2017; 14(6):523-529. PubMed ID: 28638267
[No Abstract] [Full Text] [Related]
3. Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR.
Veiga SR; Ge X; Mercer CA; Hernández-Álvarez MI; Thomas HE; Hernandez-Losa J; Ramón Y Cajal S; Zorzano A; Thomas G; Kozma SC
Clin Cancer Res; 2018 Aug; 24(15):3767-3780. PubMed ID: 29691292
[No Abstract] [Full Text] [Related]
4. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt.
Li Y; Yang DQ
Mol Cancer Ther; 2010 Jan; 9(1):113-25. PubMed ID: 20053781
[TBL] [Abstract][Full Text] [Related]
5. Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
Zakikhani M; Bazile M; Hashemi S; Javeshghani S; Avizonis D; St Pierre J; Pollak MN
PLoS One; 2012; 7(11):e49513. PubMed ID: 23185347
[TBL] [Abstract][Full Text] [Related]
6. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells.
Moolmuang B; Ruchirawat M
J Pharm Pharmacol; 2021 Mar; 73(1):40-51. PubMed ID: 33791808
[TBL] [Abstract][Full Text] [Related]
7. Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
Jaidee R; Kongpetch S; Senggunprai L; Prawan A; Kukongviriyapan U; Kukongviriyapan V
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1681-1690. PubMed ID: 32383028
[TBL] [Abstract][Full Text] [Related]
8. Phenformin synergistically sensitizes liver cancer cells to sorafenib by downregulating CRAF/ERK and PI3K/AKT/mTOR pathways.
Huang L; Xiao D; Wu T; Hu X; Deng J; Yan X; Wu J; Xu S; Yang X; Li G
Am J Transl Res; 2021; 13(7):7508-7523. PubMed ID: 34377232
[TBL] [Abstract][Full Text] [Related]
9. Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
Huang Y; Zhou S; He C; Deng J; Tao T; Su Q; Darko KO; Peng M; Yang X
Cancer Commun (Lond); 2018 Jul; 38(1):50. PubMed ID: 30053908
[TBL] [Abstract][Full Text] [Related]
10. Ataxia-telangiectasia mutated (ATM) participates in the regulation of ionizing radiation-induced cell death via MAPK14 in lung cancer H1299 cells.
Liang N; Zhong R; Hou X; Zhao G; Ma S; Cheng G; Liu X
Cell Prolif; 2015 Oct; 48(5):561-72. PubMed ID: 26269117
[TBL] [Abstract][Full Text] [Related]
11. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
[TBL] [Abstract][Full Text] [Related]
12. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.
Nadkarni A; Shrivastav M; Mladek AC; Schwingler PM; Grogan PT; Chen J; Sarkaria JN
J Neurooncol; 2012 Dec; 110(3):349-57. PubMed ID: 23054561
[TBL] [Abstract][Full Text] [Related]
13. Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway.
Shui L; Wang W; Xie M; Ye B; Li X; Liu Y; Zheng M
Aging (Albany NY); 2020 Nov; 12(23):24318-24332. PubMed ID: 33260158
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
[TBL] [Abstract][Full Text] [Related]
15. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
Harris BRE; Zhang Y; Tao J; Shen R; Zhao X; Cleary MP; Wang T; Yang DQ
FASEB J; 2021 Apr; 35(4):e21264. PubMed ID: 33715230
[TBL] [Abstract][Full Text] [Related]
16. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
Sanli T; Rashid A; Liu C; Harding S; Bristow RG; Cutz JC; Singh G; Wright J; Tsakiridis T
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):221-9. PubMed ID: 20615625
[TBL] [Abstract][Full Text] [Related]
17. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
Golding SE; Rosenberg E; Valerie N; Hussaini I; Frigerio M; Cockcroft XF; Chong WY; Hummersone M; Rigoreau L; Menear KA; O'Connor MJ; Povirk LF; van Meter T; Valerie K
Mol Cancer Ther; 2009 Oct; 8(10):2894-902. PubMed ID: 19808981
[TBL] [Abstract][Full Text] [Related]
18. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
19. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells.
Mondal A; Roberge J; Gilleran J; Peng Y; Jia D; Akel M; Patel Y; Zoltowski H; Doraiswamy A; Langenfeld J
Cell Commun Signal; 2022 Jun; 20(1):99. PubMed ID: 35761398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]